0
0
A new study suggests that a streamlined, three-question screening tool may effectively flag individuals with depression, potentially allowing clinicians to more efficiently identify those in need of mental health support. The research, involving over 96,000 adults across the United States, assessed the performance of the so-called PHQ-3—a drastically shortened version of the widely used nine-question Patient Health Questionnaire (PHQ-9).
High Sensitivity in Identifying Depression
The PHQ-3 demonstrated a sensitivity of 98% and specificity of 76% in predicting moderate or greater depressive symptoms. Sensitivity remained above 90% for all racial and ethnic groups and most age groups studied. The tool focused on just three items from the PHQ-9: interest in activities, depressed mood, and feelings of self-esteem or failure.
Dr. Roy H. Perlis, the study’s lead investigator and vice chair of research in psychiatry at Mass General Brigham, explained, “We let the data tell us what the constellation of symptoms are that best predict overall severity and how well they do at identifying depression. It’s a way we might be able to get the maximum amount of information in the shortest amount of time.” Despite these promising results, Dr. Perlis cautioned that more studies in clinical settings are needed before widespread adoption.
Why a Shorter Screen?
With the proliferation of digital health tools and increasing patient preference for brevity—especially when using smartphones or online portals—the length of questionnaires like the PHQ-9 has been a barrier. “Faced with a long list of survey questions, some individuals may be tempted to speed through or to not respond at all,” researchers noted. The PHQ-3 aims to provide quick yet reliable results, balancing the need for speed with diagnostic accuracy.
PHQ-3 as a First Step
The findings indicate that while the PHQ-3 may not capture the full spectrum of depressive symptoms, it could be an effective initial screening tool, triggering more in-depth assessment if a positive result occurs. Dr. Perlis emphasized, “What’s most important is that people are screening for depression and, if someone screens positive, that they’re following up with a more comprehensive evaluation and offering treatment if it’s indicated. It’s really about figuring out who needs follow-up.”1
Disclaimer:
This article summarizes recent research findings. The PHQ-3 is not currently recommended as a standalone diagnostic tool for depression in clinical practice. Individuals or clinicians should follow existing guidelines and seek further assessment for a comprehensive evaluation. For any concerns about depression or mental health, consult a qualified healthcare provider.
